Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Current Opinion in Immunology
|
June 7, 2022
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
Darin K Edwards, Andrea Carfi
Cell
|
March 19, 2021
Novel approaches for vaccine development
Makda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Journal of Translational Medicine
|
January 5, 2017
Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
Darin K Edwards, Edith Jasny, Heesik Yoon, et al.
Journal of Virology
|
August 28, 2024
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Baoling Ying, Chieh-Yu Liang, Pritesh Desai, et al.
Vaccine
|
February 25, 2026
Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines
Woo Yun Sohn, Susan M G Goody, David W Reid, et al.
Journal of Virology
|
September 22, 2021
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
Angela Choi, Matthew Koch, Kai Wu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 16, 2022
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Spyros Chalkias, Howard Schwartz, Biliana Nestorova, et al.
Nature Microbiology
|
April 3, 2023
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2022
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Open Forum Infectious Diseases
|
December 4, 2025
Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants
Amparo L Figueroa, Bethany Girard, Darin K Edwards, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Current Opinion in Immunology
|
June 7, 2022
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
Darin K Edwards, Andrea Carfi
Cell
|
March 19, 2021
Novel approaches for vaccine development
Makda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Journal of Translational Medicine
|
January 5, 2017
Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
Darin K Edwards, Edith Jasny, Heesik Yoon, et al.
Journal of Virology
|
August 28, 2024
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Baoling Ying, Chieh-Yu Liang, Pritesh Desai, et al.
Vaccine
|
February 25, 2026
Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines
Woo Yun Sohn, Susan M G Goody, David W Reid, et al.
Journal of Virology
|
September 22, 2021
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
Angela Choi, Matthew Koch, Kai Wu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 16, 2022
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Spyros Chalkias, Howard Schwartz, Biliana Nestorova, et al.
Nature Microbiology
|
April 3, 2023
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2022
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Open Forum Infectious Diseases
|
December 4, 2025
Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants
Amparo L Figueroa, Bethany Girard, Darin K Edwards, et al.
Page
of 6